Pharmacogenomics and regulatory decision making: an international perspective

被引：0
|
作者：
D L Mendrick
C Brazell
E A Mansfield
R Pietrusko
I Barilero
J Hackett
S Stürzebecher
D Jacobson-Kram
机构：
[1] Toxicogenomics,
[2] Gene Logic Inc.,undefined
[3] Genetics Research,undefined
[4] GlaxoSmithKline,undefined
[5] Regulatory Affairs,undefined
[6] Affymetrix Inc.,undefined
[7] Worldwide Regulatory Affairs,undefined
[8] Millennium Pharmaceuticals,undefined
[9] Inc.,undefined
[10] Global Regulatory Policy and Intelligence,undefined
[11] Johnson & Johnson Pharmaceutical Research and Development,undefined
[12] Office of In Vitro Diagnostic Device Evaluation and Safety,undefined
[13] CDRH,undefined
[14] Corporate Preclinical Development,undefined
[15] Office of New Drugs,undefined
[16] CDER,undefined
来源：
The Pharmacogenomics Journal | 2006年 / 6卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：154 / 157
页数：3
相关论文
共 50 条
  • [31] Self-other decision-making differences in loss aversion: A regulatory focus perspective
    Liu, Hongrui
    Wang, Ling
    Yao, Meilin
    Yang, Hang
    Wang, Dongmei
    JOURNAL OF APPLIED SOCIAL PSYCHOLOGY, 2017, 47 (02) : 90 - 98
  • [32] Medical decision making for older adults: an international perspective comparing the United States and India
    Kalra, Ankur
    Forman, Daniel E.
    Goodlin, Sarah J.
    JOURNAL OF GERIATRIC CARDIOLOGY, 2015, 12 (04) : 329 - 334
  • [33] Medical decision making for older adults:an international perspective comparing the United States and India
    Ankur Kalra
    Daniel E Forman
    Sarah J Goodlin
    Journal of Geriatric Cardiology, 2015, 12 (04) : 329 - 334
  • [34] ENVIRONMENTAL POLICY-MAKING AND TRIBUNAL DECISION-MAKING: ASSESSING THE SCOPE OF REGULATORY POWER IN INTERNATIONAL INVESTMENT ARBITRATION
    Jez, Areta
    UNIVERSITY OF PENNSYLVANIA JOURNAL OF INTERNATIONAL LAW, 2019, 40 (04): : 989 - 1016
  • [35] CLINICAL DECISION SUPPORTS (CDS) TO INCORPORATE PHARMACOGENOMICS (PGx) INTO DECISION MAKING IN PERIOPERATIVE CARE.
    Hikino, K.
    Danahey, K.
    Apfelbaum, J. L.
    Ratain, M. J.
    O'Donnell, P. H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S76 - S76
  • [36] Generating and weighing evidence in drug development and regulatory decision making: 5th US FDA-DIA workshop on pharmacogenomics
    Shaw, Peter M.
    Zineh, Issam
    PHARMACOGENOMICS, 2010, 11 (12) : 1629 - 1635
  • [37] A unified perspective on decision making and decision support systems
    Ayati, M.B
    Information Processing and Management, 1987, 23 (06): : 616 - 628
  • [38] Regulatory perspective on remaining challenges for utilization of pharmacogenomics-guided drug developments
    Otsubo, Yasuto
    Ishiguro, Akihiro
    Uyama, Yoshiaki
    PHARMACOGENOMICS, 2013, 14 (02) : 195 - 203
  • [39] Decision making: The patient's perspective
    Van daele, H.
    PSYCHO-ONCOLOGY, 2006, 15 (02) : S79 - S79
  • [40] Decision-Making: A Neuroeconomic Perspective
    Hardy-Vallee, Benoit
    PHILOSOPHY COMPASS, 2007, 2 (06): : 939 - 953
12345